Synthetic composition and method for treating irritable bowel syndrome

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11026959
APP PUB NO 20180169122A1
SERIAL NO

15897099

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The application relates to a method for treating a patient with irritable bowel syndrome (IBS), the method comprising administering to the patient a mixture comprising 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLYCOM A/S

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elison, Emma Hjärup, SE 19 47
Hennet, Thierry Otelfingen, CH 9 34
McConnell, Bruce La Tour de Peilz, CH 73 164
Vigsnæs, Louise Kristine København NV, DK 57 96

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 8, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 8, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 8, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00